Amgen

Companies Amgen

News Amgen

• Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab

  Synthon announced that it has entered into a global license agreement with Amgen Inc. and Watson Pharmaceuticals, Inc. for Synthon’s trastuzumab, being developed as a biosimilar to Herceptin®, which is currently approved for treatment of breast cancer and gastric cancer. Earlier this year Synthon su more

• UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

  UCB and Amgen announced the start of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical trial program for the treatment of postmenopausal osteoporosis."We look forward to working with UCB on the CDP7851/AMG 785 Phase 3 program," said Sean E. Harper, M.D., executive vice president of Resear more

• Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers

  The Amgen Foundation and European Schoolnet launched the "Amgen Science Teacher Training Initiative" in France, Germany, Ireland and Poland.The Amgen Science Teacher Training Initiative provides professional development for secondary school science teachers to help them incorporate hands-on enquiry- more

White papers Amgen

• Frost & Sullivan's Global PharmAlliance 2005: Becoming the Partner of Choice
  

  Looking at the increasing trend towards partnerships and alliances in the pharmaceutical industry, Frost & Sullivan a global growth consulting company had organized a premium conference, "Global PharmAlliance 2005 - Becoming the partner of choice" in Mumbai (India). The two day event focused on giving an insight into the world of partnerships and alliances through... more

Publications Amgen

• Amgen deal triggers watchful waiting in targeted nanomedicine

  Nature Medicine 19, 120 (2013). doi:10.1038/nm0213-120b Author: Monica Heger more

• Ligand Binding Assays in the 21st Century Laboratory: Automation

  Ligand Binding Assays in the 21st Century Laboratory: Automation Content Type Journal Article Category Commentary Pages 1-12 DOI 10.1208/s12248-012-9323-z Authors Ago B. Ahene, XOMA Corporation, 2710 Seventh Street, Berkeley, California 94710, USA Chris Morrow, Genentech, South San Fra more

• Ligand Binding Assays in the 21st Century Laboratory: Platforms

  Ligand Binding Assays in the 21st Century Laboratory: Platforms Content Type Journal Article Category Commentary Pages 1-6 DOI 10.1208/s12248-012-9321-1 Authors Franklin P. Spriggs, Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., 1 Burtt Road, MS G2002, Andover, more

Market studies Amgen

• Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Osteopenia Therapeutics market. The report identifies the more

• Algeria Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: With the push into emerging markets by pharmaceutical companies and the dangers of importing drugs into the Algerian market well documented, it makes sense that large multinational drugmakers would want to partner with local companies. High rates of foreign direct investment in the past ye more

• Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020”. The report is an essential source of information and analysis on the global ovarian cancer therapeutics market. The report provi more

Websites Amgen